Literature DB >> 7649117

Prolactin receptors and JAK2 in islets of Langerhans: an immunohistochemical analysis.

R L Sorenson1, L E Stout.   

Abstract

Lactogenic hormones, PRL and placental lactogen, are important regulators of insulin secretion and islet beta-cell proliferation. In this study we examined the presence of PRL receptor immunoreactivity in pancreatic islets of Langerhans using PRL receptor monoclonal antibodies provided by Dr. Paul Kelly. Studies were performed using islets isolated from neonatal, adult, and day 14 pregnant rats. The islets were examined by immunohistochemistry and laser scanning confocal microscopy. In neonatal rat islets, PRL receptors were observed in beta- and alpha-cells, but not in delta-cells. Among islet beta- and alpha-cells there was heterogeneity of cellular staining for PRL receptors. A small portion of the cells was intensely stained for PRL receptors. However, the majority of the cells had a much lower level of staining intensity, suggesting that most islet cells have a low level of PRL receptors. In general, alpha-cells were more uniformly stained than beta-cells. Similar results were obtained with adult rat islets, in which, again, there was a large range of staining intensity and many cells with low levels of PRL receptor. Rats on day 14 of pregnancy had an increased level of islet PRL receptor expression compared with age-matched control animals. There was also a decrease in cellular heterogeneity for PRL receptors, with nearly all cells having a uniformly high level of PRL receptor expression. JAK2, the tyrosine kinase associated with PRL receptors, was examined in Nb2 cells and islets. JAK2 immunoreactivity was detected at the cell membrane in very low levels in Nb2 cells. It was also found in numerous vesicular structures in the cytoplasm, where it colocalized with PRL receptors. A prominent feature of all cells was the presence of JAK2 in the nucleus, but not the nucleolus. In islets, JAK2 immunoreactivity was similarly observed in the nucleus of nearly all cells. However, the vesicular cytoplasmic location of JAK2 was less frequently observed and did not colocalize with PRL receptors. For comparison, JAK2 immunoreactivity was examined in several other tissues where it was detected in fibroblasts (endomysial and endoneurial cells), smooth muscle cells, and ganglion cells in the pancreas. JAK2 was notably absent from pancreas acinar cells, hepatocytes, skeletal muscle cells, and Schwann cells. This study demonstrates the presence of PRL receptors in islet beta- and alpha-cells, but not delta-cells. There was an increase in PRL receptor expression in islets during pregnancy, which is commensurate with the up-regulation of islet function. In addition, JAK2 immunoreactivity was detected in most islet cells and Nb2 node cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7649117     DOI: 10.1210/endo.136.9.7649117

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  26 in total

1.  Immunohistochemical detection of phosphorylated JAK-2 and STAT-5 proteins and correlation with erythropoietin receptor (EpoR) expression status in human brain tumors.

Authors:  M Kondyli; G Gatzounis; A Kyritsis; J Varakis; M Assimakopoulou
Journal:  J Neurooncol       Date:  2010-03-25       Impact factor: 4.130

2.  Ontogenesis of prolactin receptors in the human fetus in early gestation. Implications for tissue differentiation and development.

Authors:  M Freemark; P Driscoll; R Maaskant; A Petryk; P A Kelly
Journal:  J Clin Invest       Date:  1997-03-01       Impact factor: 14.808

3.  Lactogens protect rodent and human beta cells against glucolipotoxicity-induced cell death through Janus kinase-2 (JAK2)/signal transducer and activator of transcription-5 (STAT5) signalling.

Authors:  N Guthalu Kondegowda; A Mozar; C Chin; A Otero; A Garcia-Ocaña; R C Vasavada
Journal:  Diabetologia       Date:  2012-03-03       Impact factor: 10.122

4.  Prolactin supplementation to culture medium improves beta-cell survival.

Authors:  Toshiyuki Yamamoto; Atsuyoshi Mita; Camillo Ricordi; Shari Messinger; Atsushi Miki; Yasunaru Sakuma; Francesca Timoneri; Scott Barker; Alessia Fornoni; R Damaris Molano; Luca Inverardi; Antonello Pileggi; Hirohito Ichii
Journal:  Transplantation       Date:  2010-06-15       Impact factor: 4.939

5.  JAK2 tyrosine kinase phosphorylates and is negatively regulated by centrosomal protein Ninein.

Authors:  Jennifer Jay; Alan Hammer; Andrea Nestor-Kalinoski; Maria Diakonova
Journal:  Mol Cell Biol       Date:  2014-10-20       Impact factor: 4.272

6.  The redundant role of JAK2 in regulating pancreatic β-cell mass.

Authors:  Diana Choi; Erica P Cai; Minna Woo
Journal:  Islets       Date:  2011 Nov-Dec       Impact factor: 2.694

7.  Nuclear Import of JAK1 Is Mediated by a Classical NLS and Is Required for Survival of Diffuse Large B-cell Lymphoma.

Authors:  Fen Zhu; Byounghoon Hwang; Shigeki Miyamoto; Lixin Rui
Journal:  Mol Cancer Res       Date:  2016-12-28       Impact factor: 5.852

8.  Interleukin-6 regulates pancreatic alpha-cell mass expansion.

Authors:  Helga Ellingsgaard; Jan A Ehses; Eva B Hammar; Leentje Van Lommel; Roel Quintens; Geert Martens; Julie Kerr-Conte; Francois Pattou; Thierry Berney; Daniel Pipeleers; Philippe A Halban; Frans C Schuit; Marc Y Donath
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-21       Impact factor: 11.205

Review 9.  Beta-cell failure as a complication of diabetes.

Authors:  K J Chang-Chen; R Mullur; E Bernal-Mizrachi
Journal:  Rev Endocr Metab Disord       Date:  2008-12       Impact factor: 6.514

10.  Lactogens Reduce Endoplasmic Reticulum Stress-Induced Rodent and Human β-Cell Death and Diabetes Incidence in Akita Mice.

Authors:  Rosemary Li; Nagesha Guthalu Kondegowda; Joanna Filipowska; Rollie F Hampton; Silvia Leblanc; Adolfo Garcia-Ocana; Rupangi C Vasavada
Journal:  Diabetes       Date:  2020-04-24       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.